A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy

Clinical trial NCT02119715 · COMPLETED

Trial details

NCT number: NCT02119715
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Neutropenia Febrile Neutropenia

Start date: 2011-02-01
Primary completion: 2012-08-01
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.